With stocks having been on a tear, the arrival of September – historically the worst month of the year for stocks – may have investors… Read More »September’s Dismal Record For Stocks – And A Curious Caveat To Consider This Year
Although their contribution has received less attention than that of the big tech stocks, MedTech stocks played a major role in driving the S&P 500… Read More »What Lies Ahead For Index-Driving MedTech Stocks?
If you’re starving for income and yield in the current ultra-low-yield environment, consider this options strategy – and experience the upside of “worthless” investments. CLICK… Read More »Generating Income On “The Other Side Of An Options Transaction”
With an average yield of 7.3%, strong fundamentals, attractive valuations and solid growth potentials, these five stocks may be the “safest ultra-yield blue-chips retirees can… Read More »These 5 Stocks May Be The “Safest Ultra-Yield Blue-Chips Retirees Can Buy”
What do a high-end furniture retailer and a Brazilian digital-payments company have in common? They – and not tech titans Apple and Amazon – have… Read More »Luxury Furniture & Brazilian Digital Payments: Warren Buffett’s Best-Performing Stocks During The Pandemic
On the heels of strong quarterly earnings results, these three tech stocks — all trading for under $10 a share – may be wise buys.… Read More »3 Under-$10 Tech Stocks To Consider On The Heels Of Strong Quarterly Earnings Results
Call it the “safe” portfolio, the “bulletproof” portfolio, or the “cockroach” portfolio, this portfolio just had its best three months possible ever. CLICK HERE.
While the market seems to have fully recovered from the March selloff, most of the heavy lifting has been done by a handful of big… Read More »These Non-Tech Dividend Paying Stocks Have Been Soaring This Year
With its drug candidate having demonstrated antiviral activity against the novel coronavirus in independent laboratory testing, this small-cap biotech joins the ever-growing list of coronavirus… Read More »The Newest Coronavirus Stock
Whether it’s for COVID-19 or any other disease or disorder, there’s one key number that investors need to focus on when it comes to study… Read More »The Key Number To Study In Vaccine Study Results